Related content

Ethinylestradiol/Drospirenone: A Review of its Use as an Oral Contraceptive

By Keam S.J.   Wagstaff A.J.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 39-61

Adis International

Access to resources Recommend Favorite

A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg

By Mabrouk Mohamed   Solfrini Serena   Frascà Clarissa   Del Forno Simona   Montanari Giulia   Ferrini Giulia   Paradisi Roberto   Seracchioli Renato  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 451-454

Informa Healthcare

Access to resources Recommend Favorite

User Experience with an Oral Contraceptive Containing Ethinylestradiol 30g and Drospirenone 3mg (Yasmin ® ) in Clinical Practice

By Schultz-Zehden Beate  

Treatments in Endocrinology, Vol. 5, Iss. 4, 2006-01 ,pp. : 251-256

Adis International

Access to resources Recommend Favorite

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone

By Milsom I.   Lete I.   Bjertnaes A.   Rokstad K.   Lindh I.   Gruber C.J.   Birkhäuser M.H.   Aubeny E.   Knudsen T.   Bastianelli C.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2304-2311

Oxford University Press

Access to resources Recommend Favorite

Aromatase expression in the eutopic endometrium of myomatous uteri: The influence of the menstrual cycle and oral contraceptive use

By Maia Hugo   Pimentel Kleber   Casoy Júlio   Correia Tânia   Freitas Luis Antonio R.   Zausner Bela   Athayde Célia   Coutinho Elsimar  

Gynecological Endocrinology, Vol. 23, Iss. 6, 2007-06 ,pp. : 320-324

Informa Healthcare

Access to resources Recommend Favorite